Themis Bioscience is a startup based in Austria, 4 tracked investors.
Based in Austria, Themis Bioscience is a startup. Brouky records 4 investors associated with the company.
Themis Bioscience is a biotechnology company that develops viral-vector vaccine platforms and vaccine candidates for infectious diseases. It focuses on advancing vaccines from preclinical stages into clinical trials using its live-attenuated/viral vector technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.